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A B S T R A C T
Background
Malaria in pregnancy is associated with adverse consequences for mother and fetus. Protection with insecticide-treated nets (ITNs)
during pregnancy is widely advocated, but evidence of their benefit has been inconsistent.
Objectives
To compare the impact of ITNs with no nets or untreated nets on preventing malaria in pregnancy.
Search methods
We searched the Cochrane Infectious Diseases Group Specialized Register (February 2009), CENTRAL (The Cochrane Library 2009,
Issue 1), MEDLINE (1966 to February 2009), EMBASE (1974 to February 2009), LILACS (1982 to February 2009), and reference
lists. We also contacted researchers working in the field.
Selection criteria
Individual and cluster randomized controlled trials of ITNs in pregnant women.
Data collection and analysis
Three authors independently assessed the risk of bias in the trials and extracted data. Data were combined using the generic inverse
variance method.
Main results
Six randomized controlled trials were identified, five of which met the inclusion criteria: four trials from sub-Saharan Africa compared
ITNs with no nets, and one trial from Asia compared ITNs with untreated nets. Two trials randomized individual women and three
trials randomized communities. In Africa, ITNs, compared with no nets, reduced placental malaria in all pregnancies (risk ratio (RR)
0.79, 95% confidence interval (CI) 0.63 to 0.98). They also reduced low birthweight (RR 0.77, 95% CI 0.61 to 0.98) and fetal loss
in the first to fourth pregnancy (RR 0.67, 95% CI 0.47 to 0.97), but not in women with more than four previous pregnancies. For
anaemia and clinical malaria, results tended to favour ITNs, but the effects were not significant. In Thailand, one trial randomizing
individuals to ITNs or untreated nets showed a significant reduction in anaemia and fetal loss in all pregnancies but not for clinical
malaria or low birthweight.
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Authors’ conclusions
ITNs have a beneficial impact on pregnancy outcome in malaria-endemic regions of Africa when used by communities or by individual
women. No further trials of ITNs in pregnancy are required in sub-Saharan Africa. Further evaluation of the potential impact of ITNs
is required in areas with less intense and Plasmodium vivax transmission in Asia and Latin America.
P L A I N L A N G U A G E S U M M A R Y
Insecticide-treated nets for preventing malaria in pregnancy
In endemic areas, malaria in pregnancy is a major public health problem. It contributes to severe anaemia in the mother and low
birth weight for babies, which are associated with poor infant health and early infant death. Also the unborn child and the pregnant
woman may die from malaria in pregnancy. Protection with insecticide-treated bednets (ITNs) during pregnancy is widely advocated,
but evidence of their benefit has been inconsistent. This review found five trials of ITNs in pregnant women. The four trials in sub-
Saharan Africa compared ITNs with no nets and showed a benefit from ITNs in terms of fewer malaria infections, low birthweight
babies, and fewer babies died before delivery. The effects on severe anaemia in the mothers were inconclusive. The one trial from Asia
compared ITNs with untreated nets and showed a beneficial effect on anaemia in women and fewer babies died before delivery, but
it had no impact on other outcomes. ITNs have been shown to be beneficial and should be included in strategies to try to reduce the
adverse effects of malaria in pregnant women in endemic areas of the world.
B A C K G R O U N D
Approximately 50million pregnant women are exposed tomalaria
each year. Women are more susceptible to malaria when they be-
come pregnant, placing both themother and fetus at risk of the ad-
verse consequences (Brabin 1983; Lindsay 2000; Steketee 2001).
In areas of low and unstable malaria transmission, such as in many
regions in Asia and the Americas, women do not acquire sub-
stantial antimalarial immunity and are susceptible to episodes of
acute and sometimes severe malaria, and fetal and maternal death
(Nosten 2004). In areas with stable malaria transmission, such as
in most of sub-Saharan Africa, infection with Plasmodium falci-
parum during pregnancy is characterized by predominantly low-
grade, sometimes sub-patent, persistent, or recurrent parasitaemia.
These frequently do not result in acute symptoms but cause ma-
ternal anaemia (Guyatt 2001a) and contribute to low birthweight
(Brabin 1983; Steketee 2001), and thus may contribute to early
infant mortality (Guyatt 2001b; van Geertruyden 2004). Because
most of these infections remain asymptomatic, and therefore unde-
tected and untreated, prevention of malaria in pregnancy is viewed
as being especially important in these settings.
The World Health Organization advocates a three-pronged ap-
proach to malaria control in pregnancy that includes the use
of insecticide-treated nets (ITNs) and antimalarial drugs, either
through intermittent preventive therapy (IPT) or case manage-
ment (treatment) (WHO 2000). Another Cochrane Review con-
cluded that the prevention of malaria in pregnancy through
chemoprophylaxis or IPT is associated with reductions in placen-
tal malaria, low birthweight, severe maternal anaemia, and peri-
natal mortality in the first two pregnancies (Garner 2002). In ar-
eas of stable malaria transmission in sub-Saharan Africa, ITNs are
highly effective in reducing childhood mortality and morbidity
frommalaria (Lengeler 2004). Although ITNs are being promoted
as a major tool in the fight against malaria in pregnancy, the avail-
able evidence about their effect in pregnancy appears inconsistent.
In this review, we summarize the available evidence to date from
randomized controlled trials of the impact of ITNs on the health
of pregnant women and the birth outcome. We do not cover the
current debate on the mechanisms of delivering ITNs.
O B J E C T I V E S
To compare ITNs with no nets or untreated nets on preventing
malaria in pregnancy.
M E T H O D S
Criteria for considering studies for this review
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Types of studies
Individual and cluster randomized controlled trials.
Types of participants
Pregnant women in malaria endemic areas.
Types of interventions
Intervention
Insecticide-treated nets.
Control
No nets or untreated nets.
Women in both arms may also receive malaria chemoprophylaxis or
IPT.
Types of outcome measures
Primary
Anaemia during pregnancy
• Severe maternal anaemia (haemoglobin < 70 or 80 g/L, or
haematocrit < 21% and 25%).
• Any anaemia (haemoglobin < 10 or 11 g/dL, or
haematocrit < 30%).
• Mean haemoglobin or haematocrit.
Measures of birthweight
• Low birthweight (< 2500 g).
• Mean birthweight.
Secondary
• Clinical malaria illness during pregnancy (parasitaemic and
febrile, or a history of fever).
• Peripheral parasitaemia (presence of malaria parasites
determined by finger prick).
• Parasite density (geometric mean).
• Placental parasitaemia.
• Preterm delivery (< 37 weeks of gestation).
• Abortion or stillbirth (fetal loss).
• Neonatal death (death within first 28 days after birth).
• Infant death.
• Maternal death.
• Illness warranting hospitalization.
Search methods for identification of studies
We attempted to identify all relevant trials regardless of language
or publication status (published, unpublished, in press, and in
progress).
Databases
We searched the following databases using the search terms and
strategy described in Table 1: Cochrane Infectious Diseases Group
Specialized Register (February 2009); Cochrane Central Register
of Controlled Trials (CENTRAL), published in The Cochrane Li-
brary (2009, Issue 1); MEDLINE (1966 to February 2009); EM-
BASE (1974 to February 2009); and LILACS (1982 to February
2009).
Researchers
We contacted individual researchers working in the field for un-
published and ongoing trials. We managed to identify two PhD
theses, the work of which had only partially been published
(Shulman 1998; Njagi 2002).
Reference lists
We also checked the reference lists of all studies identified by the
above methods.
Data collection and analysis
Selection of studies
Paul Ekwaru (PE) scanned the results of the literature search for
potentially relevant trials. The full articles were retrieved, and Car-
rol Gamble (CG) and PE independently assessed them for inclu-
sion in the review using an eligibility form based on the inclusion
criteria. We planned to resolve disagreements through discussion
or by contacting a mediator (Aika Omari (AO)). Although there
were no disagreements, AOhelped clarify some clinical definitions
and terminology.
Data extraction and management
CGandPE independently extracted data relating to characteristics
of the trials and participants, and the reported outcome measures.
We planned to resolve any discrepancies in the extracted data by
referring to the original paper and through discussion; there were
no disagreements.
Where possible we extracted data to allow an intention-to-treat
analysis. If the number randomized and the numbers analysed for
each outcome were inconsistent, we calculated the percentage loss
to follow up and recorded this information.
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For dichotomous outcomes, we recorded the number of partici-
pants experiencing the event in each group. For the continuous
outcomes, we extracted means (arithmetic and geometric) and a
measure of variance (standard deviation, standard error, or confi-
dence interval) for each group.
Where trials had been randomized using clusters, we recorded
whether the analysis accounted for the clustering effect and, when
available, extracted results that adjusted for the clustering. This
means extracted data were comparative outcome measures (risk
ratios (RR), odds ratios (OR), hazard ratios) with 95% confidence
intervals (CI). We also recorded the method used to adjust for
clustering and whether the analysis adjusted for additional covari-
ates.
Assessment of risk of bias in included studies
CG, PE, and Feiko ter Kuile (FK) independently assessed the risk
of bias in the trials by describing the methods used to generate
the allocation sequence and allocation concealment as adequate,
inadequate, or unclear according to Jüni 2001. We considered
blinding by recording whether the participants, investigators, or
outcome assessors were aware of the treatment group allocation
and recorded the studies description of blinding (open, single, or
double) when provided. We considered inclusion of all random-
ized participants in the analysis as adequate (90% or more of the
participants randomized included in the analysis), unclear (not re-
ported), and inadequate (less than 90% participants randomized
into the trial included in the analysis).
Data synthesis
CG entered the data into Review Manager 5. We anticipated four
types of study design:
1. Cluster randomized: villages randomized and nets intended
for the whole community.
2. Cluster randomized: villages or antenatal clinics
randomized, but only the pregnant women are allocated to nets
or no nets.
3. Individually randomized: pregnant women randomized to
nets or no nets.
4. Individually randomized: as 3. but pregnant women are a
subgroup of all those randomized.
A mass effect related to the area-wide killing of the malaria trans-
mitting mosquitoes is expected to exist with an intervention for
the whole community (Hawley 2003), as in 1. Studies that ran-
domized communities (villages or antenatal clinics) need to ac-
count for clustering in the analysis. Ignoring the clustering leads to
too narrow confidence intervals and small P values, and is likely to
produce wrong conclusions (Kerry 1998). The decision was made
a priori not to combine trials with different comparator groups
(no nets or untreated nets).
All cluster randomized trials reported comparative outcome mea-
sures with 95% confidence intervals adjusted for clustering, unless
otherwise stated. The chosen outcome measure varied between
cluster randomized trials. It is not meaningful to combine hazard
ratios with odds ratios or risk ratios. In trials that randomize indi-
viduals it is possible to convert odds ratios to risk ratios and vice
versa if information is available about the probability of the event
in each group (Deeks 2001). A similar approach was considered
using average event rates across clusters, but this information was
not available. Alternatively, odds ratios approximate risk ratios if
the event is rare (Deeks 2005). Where event rates were presented
with odds ratios, we considered them to approximate risk ratios if
the event rate was less than 10%. Where meta-analysis was pos-
sible, we combined outcomes using the generic inverse variance
method.
We assessed heterogeneity amongst trials by inspecting the forest
plots, using the chi-squared test for heterogeneity with a 10% level
of statistical significance, and using the I2 statistic with a value of
50% representingmoderate heterogeneity.We planned to perform
subgroup analyses to explore the following potential sources of
heterogeneity although in most cases there were too few trials to
permit this: inclusion of trials randomizing individuals or clusters
(herd effect); women of different gravidity; use of co-interventions
such as IPT; and differences in transmission intensity due to season
and geographical location. In the presence of heterogeneity of trial
effects, and where it remained clinically logical to combine trials
we used the random-effects model; otherwise we used the fixed-
effect model.
Because parity was considered the greatest potential modifier of
the effect of ITNs (with the greatest effect of ITNs anticipated
in women with fewer previous pregnancies), we aimed to stratify
the analyses by groups according to the number of previous preg-
nancies (less than three, and three or more) whenever details were
provided. One trial included women with no previous pregnan-
cies only and one included no or one previous pregnancy only. Of
the three trials that included women regardless of the number of
previous pregnancies, ter Kuile 2003 reported details of the mag-
nitude of effect by two groups, one for women with in their first
pregnancy with those with up to three previous pregnancies and
one for women with at least four previous pregnancies. Browne
2001 provided subgroups by no, one, and two or more previous
pregnancies for all continuous outcome measures (birthweight,
haemoglobin, and parasite densities), but not for the dichotomous
outcomes. Although Browne 2001 provided proportions grouped
by the number of previous pregnancies, cluster-adjusted estimates
of the precision of effect were only available for the overall effect
and not by gravidity groups. Shulman 1998 only included women
in their first pregnancy, and Njagi 2002 included women in their
first or second pregnancy. Dolan 1993 did not provide estimates
by the number of previous pregnancies, except for the effect on
birthweight.
To consider the effect of ITNs and IPT alone and in combination,
we conducted a secondary analysis that excluded those trials that
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also used IPT (analyses not shown).
We pooled the data for women with two or more previous preg-
nancies in Browne 2001 with those from women with four or
more previous pregnancies in ter Kuile 2003 to obtain summary
estimates. Similarly we pooled data from women with no to three
previous pregnancies from ter Kuile 2003 with the data for women
in their first or second pregnancy from Shulman 1998, Browne
2001, and Njagi 2002.
We planned to consider publication bias using a funnel plot, but
there were too few trials. Funnel plot asymmetry could be caused
by publication bias, differences in design (cluster or individual ran-
domization), methodological quality, or heterogeneity of results.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Eligibility
Seven studies of ITNs in pregnant women were identified, of
which six were randomized controlled trials of ITNs in preg-
nancy that were potentially eligible for inclusion (Dolan 1993;
D’Alessandro 1996; Shulman 1998; Browne 2001; Njagi 2002;
ter Kuile 2003). The other was a social marketing study (Marchant
2002). We excluded D’Alessandro 1996, a cluster randomized
controlled trial from The Gambia of women in their first preg-
nancy, for the reasons given in the ’Characteristics of excluded
studies’. This left five trials that met the inclusion criteria (see
’Characteristics of included studies’).
All five trial reports were published in English. Three trials (all
in Africa) randomized entire communities and reported on preg-
nant women as a subgroup (Shulman 1998; Browne 2001; ter
Kuile 2003), while the other two randomized individual pregnant
women (Dolan 1993; Njagi 2002). All three trials that random-
ized entire communities (cluster randomized) took the clustering
effect into account in their analysis, and the data supplied allowed
the meta-analysis to take design effects into account.
Setting
The included trials were conducted in Kenya (Shulman 1998;
Njagi 2002; ter Kuile 2003), northern Ghana (Browne 2001), and
in refugee camps for the Karen people on the Thai-Burmese border
(Dolan 1993). Malaria transmission rates varied, as described in
the ’Characteristics of included studies’.
Participants and methods
The trials included a total of 6759 pregnant women. Three trials
recruited women of all parity groups (Dolan 1993; Browne 2001;
ter Kuile 2003), one trial recruited women having their first or
second baby (Njagi 2002), and one trial recruited women having
their first baby (Shulman 1998). In the cluster randomized trials,
Browne 2001 included 1961 women (96 clusters), ter Kuile 2003
included 2991 pregnant women of all gravidity (79 clusters), and
Shulman 1998 included 503 women (56 clusters). In the indi-
vidually randomized trials, Dolan 1993 included 341 women and
Njagi 2002 included 963 women.
The trials distributed the nets at different times: one year before
the start of the nested study in pregnant women in Shulman 1998
and Browne 2001; by the start of the trial, January 1997, in ter
Kuile 2003; and as they randomized individuals at the time of
recruitment in Njagi 2002 and Dolan 1993. As the distribution
of nets was completed well in advance of the start of the trials in
Shulman 1998 and Browne 2001, women at any stage of their
pregnancywho attended the study clinic or hospital were included.
ter Kuile 2003 included women at any stage of pregnancy but
excluded those with an expected delivery date before 12 July 1997
a priori from the analysis to allow sufficient time for the nets to
impact on intrauterine growth and gestational age. Njagi 2002
considered women eligible if the gestational age was estimated to
be between 12 and 24 weeks. Dolan 1993 recruited women as
soon as they attended the antenatal clinic and reported that this
was usually at the end of the first trimester.
Clinical management of anaemia and malaria during follow
up
The frequency of blood tests to detect parasitaemia and haemo-
globin and/or haematocrit levels varied between the trials.
Dolan 1993 provided weekly antenatal care during which blood
films were taken for malaria and measured haematocrit levels fort-
nightly. P. falciparum infections were treated with oral quinine if
uncomplicated or with intravenous quinine if severe. P. vivax in-
fections were treated with chloroquine. Women with haematocrit
levels below 30% received ferrous sulphate and folic acid until
delivery.
In Shulman 1998, a blood sample was taken in the third trimester
(between 28 and 34 weeks) or at any time that a woman was sus-
pected of being severely anaemic. All women with haemoglobin
levels less than 10 g/dL received haematinics, and those with par-
asitaemia were treated with sulfadoxine-pyrimethamine. Women
found to be severely anaemic (haemoglobin < 70 g/L) were also
given sulfadoxine-pyrimethamine.
Browne 2001 reported that the clinic visits followed the same
pattern as routine antenatal care; further details are not provided.
Njagi 2002 treated women with sulfadoxine-pyrimethamine if
they developed an episode of symptomatic malaria during preg-
nancy. All women received standard care during routine antenatal
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clinic visits plus routine iron and folic acid supplementation ac-
cording to antenatal clinic guidelines. Women with haemoglobin
levels less than 80.0 g/L were also given treatment doses of ferrous
sulphate (6 mg/kg/day) and folic acid (0.5 mg/day) until delivery.
The trial by ter Kuile 2003 was conducted in two contigenous
areas: a ’non-cohort’ area (60 villages) and a ’cohort’ area (the re-
maining 19 villages) where a birth-cohort study was conducted.
Birth outcomeswere collected in all clusters, but only in the cohort
area were women followed monthly throughout pregnancy to de-
termine the incidence of malaria and anaemia. Women with clini-
cal malaria were treated with sulfadoxine-pyrimethamine.Women
with haemoglobin levels less than 80 g/L were given ferrous sul-
phate supplementation and those with levels less than 50 g/L were
referred to hospital. Routine antenatal care was available in the
noncohort villages.
IPTwith sulfadoxine-pyrimethamine had not yet been introduced
as policy for the prevention of malaria in pregnancy in any of the
study areas at the time of the trial, with the exception of Njagi
2002. This trial provided IPT with sulfadoxine-pyrimethamine to
half of the women as part of the study design, and the other half
received placebo IPT.
Timing of outcome collection
In determining whether it is reasonable to combine data for partic-
ular outcomes the timing of the outcomes also needs to be consid-
ered. Malaria and anaemia outcome measures may be determined
by blood tests during pregnancy or by blood tests taken at the time
of delivery. Shulman 1998 and Browne 2001 reported haemoglo-
bin and parasitaemia outcomes based on a blood test during the
third trimester, while Njagi 2002 and ter Kuile 2003 took mea-
surements at the time of delivery. We pooled the results of the pe-
ripheral malarial smears and the haematological assessment in the
third trimester from Shulman 1998 and Browne 2001 with the
respective assessments conducted at the time of birth from Njagi
2002 and ter Kuile 2003 and reported these in the text only. ter
Kuile 2003 also took measurements throughout follow up and re-
ported hazard ratios to account for participants lost during the fol-
low-up period and those whowere followed up for variable lengths
of time. Dolan 1993 took weekly blood films for malaria and con-
ducted fortnightly tests for haematocrit levels, and reported their
incidence during follow up and at the time of delivery.
Sample size calculations
The outcome measures used for the sample size calculations varied
between the trials. Shulman 1998 powered the study to detect a
halving in the prevalence of severe anaemia, an increase in mean
haemoglobin of 7.5 g/L, and a 30% reduction in the prevalence
of placental anaemia with 80% power and 95% confidence. Full
parameters required to replicate the sample size calculations are
not provided.
Browne 2001 based the sample size on a 40% reduction in parasite
prevalence, which was estimated at 50% in the no nets group.
They used 90% power, 95% confidence, and inflated the sample
size by 15% for clustering and 10% for losses to follow up.
Njagi 2002 powered the study to detect differences based on mean
haemoglobin and birthweight. They considered an increase in hae-
moglobin of 5 g/L (from a 100 g/Lmeanwith a standard deviation
of 15 g/L) and an increase in birthweight of 150 g (from a mean
of 3000 g standard deviation of 500 g) to signify an important dif-
ference. They used 80% power and 95% confidence, and inflated
sample size calculations by 25% to allow for losses to follow up.
ter Kuile 2003 was designed to detect a 25% reduction in the
prevalence of adverse birth outcomes, defined as low birthweight,
pretermbirth, or small for gestational age deliveries amongwomen
in their first or second pregnancy with 80% power and 95% con-
fidence. This allows for a design effect (clustering) of 1.2 assuming
that data would be collected on 80% of the deliveries within 96
hours of birth. The proportion used for adverse birth outcomes in
the sample size calculations is not stated.
Dolan 1993 had 90% power and 95% confidence to detect a
change in malaria incidence of 37% in the untreated nets groups
to 15% in the treated nets group.
Interventions
All four trials conducted in Africa compared ITNs with no nets
(Shulman 1998; Browne 2001; Njagi 2002; ter Kuile 2003). The
remaining trial, conducted in Thailand, compared ITNs with un-
treated nets (Dolan 1993). All trials used the widely available in-
secticide permethrin (500 g/m2), except Njagi 2002, which used
cyfluthrin.
Dolan 1993 randomized individuals to receive either ITNs, un-
treated nets, or no nets. In the ’no-nets’ arm, a large proportion of
women received nets from another donor independent to the trial,
and the researchers split the results in this control arm into women
using donor nets and women not using donor nets. Because this
compromised the validity of the control arm, we only present the
comparison of ITNs versus untreated nets.
The trial by Njagi 2002 used a factorial design comparing the
effect of ITNs with IPT plus sulfadoxine-pyrimethamine.Women
were allocated to four groups: nets plus IPT, IPT alone, ITNs
alone plus placebo IPT, or placebo IPT alone (case management).
Shulman 1998, Browne 2001, and ter Kuile 2003 all provided
multiple bed nets to allow use by all members of the households.
Shulman 1998 andNjagi 2002 used nets that were 190 cm (width)
by 180 cm (length) by 150 cm (height), while Browne 2001 pro-
vided four different sizes ranging from 100 cm to 190 cm in width.
ter Kuile 2003 did not provide the size of the nets other than
that they were a large family size (Phillips-Howard 2003). Dolan
1993 used single-sized nets that were relatively small in size, 70
cm (width) by 180 cm (length) by 150 cm (height). Thus while in
both Dolan 1993 and Njagi 2002 pregnant women were provided
with nets as part of antenatal care, only in Njagi 2002 were they
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of a sufficient size to allow more than one person to sleep under
them.
Study subgroups
Three trials presented the results in subgroups. Browne 2001 used
six subgroups, each divided according to the number of pregnan-
cies (one, two, and three or more) and season (wet or dry). Njagi
2002 used subgroups based on the use of IPT. ter Kuile 2003 used
two subgroups based on the number of pregnancies, one to four,
and five or more.
Risk of bias in included studies
See Table 2.
Three of the included trials (Shulman 1998; Browne 2001; ter
Kuile 2003) are linked to trials included in another Cochrane Re-
view of ITNs that excluded pregnant women (Lengeler 2004). In
assessing the risk of bias in these trials for this review, information
has been drawn from publications and also from Lengeler 2004
who had access to additional unpublished information.
Generation of allocation sequence
Four trials used random-number tables or open lotteries to gener-
ate the allocation sequence; the methods for the cluster random-
ized trials are described in more detail elsewhere (Binka 1996;
Nevill 1996; Phillips-Howard 2003; Lengeler 2004). One trial
does not describe the method used (Dolan 1993).
Allocation concealment
Three trials used adequate methods to concealed allocation. Two
did not report on this (Dolan 1993; Njagi 2002).
Blinding
Dolan 1993 achieved double blinding in the comparison between
ITNs and untreated nets, but it was open for the comparison with
no nets (not included in this review). Blinding was not possible
in the remaining four trials that compared ITNs with no nets
and were classified as open. Njagi 2002 achieved double blinding
between sulfadoxine-pyrimethamine and placebo.
Inclusion of all randomized participants in the analysis
The number of participants followed up was adequate (90% or
more) in four of the five trials for at least one outcome. In Browne
2001, data from 92% of the 1961 participants were available for
analysis of one of the primary outcomes (haematological impact in
the third trimester), but birthweight and birth outcome data were
available for only 847 women due to the change from active to pas-
sive surveillance of deliveries after six months because of resource
constraints. In Shulman 1998, 91.8% had a third trimester blood
sample taken, and 98.8% were followed up at least four weeks
after delivery, but only those giving birth in hospital (25.8%) con-
tributed to birthweight outcomes.
Effects of interventions
1. ITNs versus no nets
Anaemia during pregnancy
Severe anaemia (haemoglobin < 70 or 80 g/L)
Three cluster randomized controlled trials reported on severe
anaemia (Shulman 1998; Browne 2001; ter Kuile 2003), see
Analysis 1.1. As the occurrence of severe anaemia was not a rare
event, we could not combine the risk ratio in ter Kuile 2003 with
the odds ratios presented in Shulman 1998 and Browne 2001. In-
sufficient details were available to allow stratification by gravidity
for Browne 2001. The pooled odds ratio of Shulman 1998 and
Browne 2001 shows a non-significant trend towards fewer with
severe anaemia in the ITNs group (0.77, 95% CI 0.56 to 1.08).
Similar non-significant trends were seen with ter Kuile 2003 for
women in their first to fourth pregnancy (measured at the time of
delivery: RR 0.80, 95% CI 0.48 to 1.33; and with the hazard ratio
of 0.70 (95% CI 0.42 to 1.16) reflecting the delay in time to first
severe anaemic episode during pregnancy. Confidence intervals in
all trials were wide. The direction of effect for women in their fifth
or greater pregnancy in ter Kuile 2003 favoured the use of no nets
but again the confidence interval width was wide.
Any anaemia (haemoglobin < 100 or 110 g/L)
Three trials, two cluster randomized, reported any anaemia, see
Analysis 1.2. Overall the point estimate was in the direction of
protection, and this was significant in the incidence data from ter
Kuile 2003 for women in their first to third pregnancy.
Combining odds ratios based on blood tests during the third
trimester (Browne 2001) with those at the time of delivery (Njagi
2002 +SP; Njagi 2002 -SP) gave a pooled odds ratio of 0.91 (95%
CI 0.67 to 1.24, fixed-effect model; analysis not shown). This
changed to an odds ratio of 0.83 (95% CI 0.68 to 1.02) when
we excluded women randomized to receive IPT with sulfadoxine-
pyrimethamine (Njagi 2002 +SP).
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Haemoglobin (g/L)
Four trials, of which three were cluster randomized (Shulman
1998; Browne 2001; ter Kuile 2003), reported haemoglobin levels
in late pregnancy or at delivery.
Shulman 1998 andBrowne 2001 reported results based on a blood
test during the third trimester whileNjagi 2002 and ter Kuile 2003
reported results at the time of delivery, see Analysis 1.3. There is
a large degree of uncertainty in the estimates, with no obvious
consistency of direction apparent.
For haemoglobin results at the time of the delivery, the cluster-
randomized ter Kuile 2003 included women in their first to fourth
pregnancywhile the individually randomizedNjagi 2002 included
women in their first or second pregnancy. Excluding Njagi 2002
+SP from this meta-analysis to allow a comparison of ITNs alone
gave a mean difference of 4.06 (95% CI 0.52 to 7.59; analysis not
shown).
Combining results for women in their first or second pregnancy
(ter Kuile 2003 included women in their first to fourth preg-
nancy) taken during the third trimester with those at the time
of delivery gave a pooled mean difference of 0.64 (95% CI -
1.50 to 2.78, fixed-effect model; analysis not shown). When we
excluded women randomized to receive IPT with sulfadoxine-
pyrimethamine (Njagi 2002 +SP) this changed to 1.17 (95% CI
-1.14 to 3.47; analysis not shown).
Measures of birthweight
Low birthweight
Two cluster randomized (Browne 2001; ter Kuile 2003) and one
trial randomizing individuals (Njagi 2002) reported low birth-
weight; see Analysis 1.4. Browne 2001 presented results as odds
ratios adjusted for clustering for all gravidity (OR 0.87, 95% CI
0.63 to 1.20; analysis not shown). As low birthweight in Browne
2001 is a common event and results are for all gravidity, we did
not consider the odds ratios to approximate risk ratios to allow a
meta-analysis with ter Kuile 2003.
AsNjagi 2002 randomized individuals, we could express the results
as risk ratios for pooling with ter Kuile 2003. The pooled result
for women in their first or second pregnancy (ter Kuile 2003 also
included women in their third and fourth pregnancies) shows a
statistically significant effect of ITNs (RR 0.77, 95% CI 0.61 to
0.98). Excluding the trial arm that used IPT (Njagi 2002 +SP)
from the meta-analysis to allow comparison of ITNs alone gave a
risk ratio of 0.71 (95% CI 0.54 to 0.92; analysis not shown).
There was no apparent benefit of ITNs for women in their fifth
or greater pregnancy or where both groups received sulfadoxine-
pyrimethamine. The wide confidence intervals include potentially
clinically important effects which could not be ruled out by these
results.
Birthweight (kg)
Four trials, of which three were cluster randomized (Shulman
1998; Browne 2001; ter Kuile 2003), reported birthweights; see
Analysis 1.5. Although the directions of the individual point es-
timates vary, the individual confidence intervals overlap. The sta-
tistically significant overall pooled result favours ITNs (mean dif-
ference 0.06 kg, 95% CI 0.02 to 0.09). Excluding the trial arm
that used IPT (Njagi 2002 +SP) from the meta-analysis of women
in their first or second pregnancy to allow a comparison of ITNs
alone gave a mean difference of 0.07 kg (95% CI 0.03 to 0.10;
analysis not shown).
Clinical malaria illness during pregnancy
Two trials, both cluster randomized, reported data on the episodes
of clinical malaria; see Analysis 1.6.
Shulman 1998 reported an odds ratio of 0.85 (95% CI 0.47 to
1.54) for women in their first pregnancy. Malaria illness was self
and health personnel diagnosed.
ter Kuile 2003 reported a hazard ratio of 0.72 (95% CI 0.19 to
2.75), which was based on monthly blood tests during follow up
for women in their first to fourth pregnancy with clinical malaria,
defined as any parasitaemia with fever. There were not enough
episodes of clinical malaria to allow an estimate of the hazard ratio
in women in their fifth or greater pregnancy.
Peripheral parasitaemia (presence of parasites determined
by finger prick)
Four trials, three cluster randomized (Shulman 1998; Browne
2001; ter Kuile 2003), reported peripheral parasitaemia;see
Analysis 1.7. Two trials based results on a blood test in the third
trimester, either for women in their first pregnancy only (Shulman
1998) or for all pregnancies (Browne 2001). ter Kuile 2003 re-
ported hazard ratios split by the number of pregnancies (one to
four, and five or more) based on monthly blood tests throughout
follow up and risk ratios at the time of delivery. Njagi 2002 ran-
domized individual women in their first or second pregnancy and
based results on a blood test at the time of delivery. All pooled
results support the use of ITNs, with the risk ratio at the time of
delivery and the hazard ratio achieving statistical significance.
Excluding the results for ter Kuile 2003 with five ormore pregnan-
cies at the time of delivery, to allow comparison of results within
women with lower numbers of pregnancies, changed the risk ratio
to 0.76 (95% CI 0.66 to 0.85; analysis not shown). By further
excluding the trial arms that used IPT (Njagi 2002 +SP) to al-
low comparison of ITNs alone within these women, the risk ratio
changed to 0.74 (95% CI 0.65 to 0.85; analysis not shown).
Parasite density (geometric mean)
Browne 2001 (cluster randomized) and Njagi 2002 reported de-
tails on parasite density; see Analysis 1.8. A geometric mean ratio
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looks at how many times bigger or smaller the geometric mean of
parasite density in the ITNs group is compared with the no nets
group. This means that the value of no difference between the
groups is one. The pooled result for women in their first or sec-
ond pregnancy favoured the use of ITNs although the result was
not statistically significant (geometric mean ratio 0.82, 95% CI
0.66 to 1.02). For women in their third or greater pregnancy, the
direction of the result favoured no nets, but the confidence inter-
vals were wide (geometric mean difference 1.28, 95% CI 0.90 to
1.82). By excluding the trial arm that used ITNs plus IPT (Njagi
2002 +SP) from the meta-analysis of women in their first or sec-
ond pregnancy to allow a comparison of ITNs alone, the geomet-
ric mean ratio changed to 0.92 (95% CI 0.71 to 1.20; analysis
not shown). ter Kuile 2003 reported that maternal and placental
parasite densities were identical in parasitaemic women from the
ITN and control villages, but insufficient details were provided
for inclusion in this analysis.
Placental parasitaemia
Two cluster randomized trials (Shulman 1998; ter Kuile 2003) and
one individually randomized trial (Njagi 2002) reported placental
parasitaemia; see Analysis 1.9.
Shulman 1998 reported results based on women in their first preg-
nancy who delivered in hospital. A placental smear was available
for 120 women (9/71 ITNs and 3/52 no nets) and a placenta
histology for 128 women (54/75 ITNs and 41/53 no nets), but
the results were not adjusted for clustering because of the small
number of women.
Analysis 1.9 shows the pooled risk ratio using the placental smear
results for Shulman 1998. Although the chi-squared test for het-
erogeneity and I2 value are of borderline significance, there is vi-
sual evidence of heterogeneity and hence we used the random-
effects model, giving a combined risk ratio of 0.82 (95% CI 0.61
to 1.11) for first or second pregnancy. Excluding the trial arm that
used ITNs plus IPT (Njagi 2002 +SP) to allow comparison of
ITNs alone gave a risk ratio of 0.76 (95%CI 0.54 to 1.07; analysis
not shown) for women in their first or second pregnancy and 0.74
(95% CI 0.59 to 0.92) overall parity.
Using the histology data from Shulman 1998 instead of the pla-
cental smear results gave a combined risk ratio of 0.82 (95% CI
0.68 to 1.00; analysis not shown) for first or second pregnancy
with overall pooled risk ratio of 0.81 (95% CI 0.69 to 0.95; anal-
ysis not shown). Excluding the trial arm that used ITNs plus IPT
(Njagi 2002 +SP) to allow comparison of ITNs alone gave a risk
ratio of 0.79 (95%CI 0.65 to 0.97; analysis not shown) for women
in their first or second pregnancy and 0.79 (95% CI 0.63 to 0.98)
overall parity.
Results from ter Kuile 2003 favoured the use of ITNs in women
on their fifth or greater pregnancy, but they were not statistically
significant.
Preterm delivery (< 37 weeks of gestation)
ter Kuile 2003 compared preterm deliveries for women living in
villages provided with ITNs and control villages without nets.
There was no statistically significant difference for women in their
first to fourth pregnancy (RR 0.66, 95% CI 0.34 to 1.29; analysis
not shown) or those in their fifth or greater pregnancy (RR 1.02,
95% CI 0.33 to 3.15; analysis not shown).
Fetal loss
Four trials, three of them cluster randomized (Shulman 1998;
Browne 2001; ter Kuile 2003), reported the frequency of fetal
loss; see Analysis 1.10. Each trial reported on this outcome mea-
sure slightly differently: Shulman 1998 reported an odds ratio
for stillbirth in women in their first pregnancy (45/1000 (ITNs
group) women followed up compared with 70/1000 (no nets); ter
Kuile 2003 reported a risk ratio for abortion and stillbirth split by
number of pregnancies (one to four, and five or more); Browne
2001 reported 15 stillbirths and 18 abortions without giving the
breakdown by intervention groups or gravidity; and Njagi 2002
reported on abortions and stillbirths in women in their first or
second pregnancy in the ITNs plus sulfadoxine-pyrimethamine
group (8/205), sulfadoxine-pyrimethamine group (11/191), ITNs
alone group (12/206), and no intervention group (17/1880).
As the event is rare (< 10%), the odds ratio reported by Shulman
1998 will approximate a risk ratio, and we have combined it with
the risk ratios reported by Njagi 2002 and ter Kuile 2003. For
women in their first or second pregnancy (ter Kuile 2003 includes
women in their third to fourth pregnancy) there is a statistically
significant decrease in the risk of fetal loss (RR 0.67, 95% CI 0.47
to 0.97). Excluding the trial arm that used both ITNs and IPT
(Njagi 2002 +SP) from this meta-analysis to allow comparison of
ITNs alone gave a risk ratio of 0.67 (95%CI 0.45 to 1.00; analysis
not shown). There was no evidence of a decrease in women with
four or more previous pregnancies.
Neonatal death (death within first 28 days after birth)
Shulman 1998 observed 14 neonatal deaths, of which four oc-
curred after seven days of age, and reported that they were spilt
equally between the ITNs and no nets groups.
Infant death (death within one year of birth)
This outcome measure was not reported.
Maternal death
Njagi 2002 reported four maternal deaths, two in the ITNs
plus sulfadoxine-pyrimethamine group, one in the sulfadoxine-
pyrimethamine group, and one in the placebo group. Shulman
1998 reported four deaths but not the groups the deaths occurred
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in; one was due to each of severe anaemia and malaria, eclampsia,
breast cancer, and a road accident.
Illness warranting hospitalization
This outcome measure was not reported.
2. ITNs versus untreated nets
One individual randomized controlled trial compared ITNs with
untreated nets (Dolan 1993).
Any anaemia during pregnancy
ITNs were associated with a reduction in anaemia (haematocrit <
30%) in all the refugee camps (study sites) and women of all gravi-
dae. After adjusting for number of pregnancies and the refugee
camps, the risk ratio was 0.63 (95% CI 0.42 to 0.93; analysis not
shown) for ITNs compared with untreated nets providing a sta-
tistically significant result favouring the ITNs.
Measures of birthweight
Low birthweight
There was no statistically significant difference between the
women using ITNs (15/94) compared with those using untreated
nets (13/85) (RR 1.04, 95% CI 0.52 to 2.07; analysis not shown).
Birthweight
Dolan 1993 reported no statistically significant difference for
birthweight. Although the trial report presents means and stan-
dard deviations for women in their first pregnancy (ITNs 2493
g (544 g) versus untreated nets 2676 g (464 g)) and those with
one or more previous pregnancies (ITNs 2940 g (436 g) versus
untreated nets 2945 g (473 g)), the number of participants was
not provided, which means that a 95% confidence interval for the
difference in means could not be calculated.
Peripheral malaria parasitaemia
Risk ratios of the incidence of P. falciparum per 1000 person weeks
were 0.39 (95% CI 0.37 to 0.82) for the Shoklo camp and 1.1
(95% CI 0.57 to 2.12) for the Bono and Maesalit camps; analyses
not shown. The presented results are adjusted for gravidity.
Preterm delivery
Dolan 1993 reported that 13/80 (16%) women in the ITNs group
and 13/73 (18%) women in the untreated nets group delivered
prematurely (RR 0.92, 95% CI 0.45 to 1.88; analysis not shown).
Fetal loss
Fetal loss amounted to 2/102 (2%) in the ITNs group and 10/97
(10%) reported in the untreated nets group. The risk ratio shows
a protective effect of ITNs over the untreated nets (RR 0.21, 95%
CI 0.05 to 0.92; analysis not shown).
Infant death
Dolan 1993 reported 11/50 (18%) deaths in the ITNs group and
10/64 (16%) in the untreated nets group (RR 1.33, 95% CI 0.61
to 2.93; analysis not shown).
Maternal death
There were two deaths among the untreated nets groups. One
woman died of severe malaria and the other of eclampsia, both
after being absent from the antenatal clinic for at least one week.
Illness warranting hospitalization
Five women were hospitalized; three were referred to hospital at
the time of delivery for abnormal presentation of fetus (two from
the ITNs group, one in the untreated nets group), and two were
treated for post-partum haemorrhage (both in the ITNs group).
D I S C U S S I O N
Despite over 80 studies of ITNs (reviewed in Lengeler 2004), only
six were randomized controlled trials that addressed the effect on
malaria in pregnancy, half of which were conducted in Kenya.
All six trials used the widely available insecticide permethrin (500
g/m2), except one trial that used cyfluthrin (Njagi 2002). The
first cluster randomized controlled trial in sub-Saharan Africa was
conducted inTheGambia in the early 1990s (D’Alessandro 1996),
but it was excluded from this review for reasons described in the
’Characteristics of excluded studies’.
Although the aim was to present meta-analysis results subgrouped
by women in their first or second pregnancy and those in their
third or greater pregnancy, this was not possible. Browne 2001
presented detailed results only by number of pregnancies for con-
tinuous outcome measures, and ter Kuile 2003 presented results
by number of previous pregnancies (none to three, and four or
more). The results could be stratified by combining women with
none to three previous pregnancies from ter Kuile 2003 with the
women in their first or second pregnancy in the other trials, and
by combining the women in their third or greater pregnancy in
the trial fromGhana (Browne 2001) with the women in their fifth
or greater pregnancy from the trial in western Kenya (ter Kuile
2003). Despite these limitations, when we combined the results
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from the four trials in Africa, ITNs were associated with signifi-
cant reductions in peripheral and placental malaria parasitaemia,
low birthweight, and fetal loss. This effect was only evident in the
subgroups of women with few previous pregnancies; there was no
evidence for a statistically significant beneficial effect in women
with at least two or more previous pregnancies.
Malaria infection: ITNs reduced the frequency of placental
malaria and peripheral parasitaemia at the time of delivery. The
peripheral parasite densities among infected women were lower
in those in their first or second pregnancy, but this was not seen
in women with at least two previous pregnancies. There was no
significant reduction in the occurrence of self reported or micro-
scopically confirmed episodes of clinical malaria.
Birthweight and preterm delivery: ITNs were associated with a
mean increase of 50 grams (95%CI 20 to 90 grams) in birthweight
in women with few previous pregnancies and a 23% reduction in
low birthweight. There was no evidence for a beneficial effect on
low birthweight in women with at least two previous pregnancies
or in women protected by IPT with sulfadoxine-pyrimethamine.
No significant decrease in the number of babies delivered prema-
turely was observed in the single trial that assessed this outcome.
Fetal loss: The risk of fetal loss decreased with the use of ITNs by
women in their first or second pregnancy, but again this decrease
was not seen in women with at least two previous pregnancies.
Anaemia: The methodology used to determine and analyse the
impact on haemoglobin and anaemia varied considerably between
the trials, which limited the ability to combine the results. The
overall impact of ITNs on haemoglobin levels or anaemia was in-
conclusive. There is some support from the two trials in western
Kenya that ITNs provide beneficial effects on mean haemoglobin
levels in women with few previous pregnancies at the time of de-
livery. However, no significant beneficial effect on severe anaemia
was seen in the other two trials from Africa that assessed haemo-
globin in the third trimester, although the effect estimate was in
favour of ITNs.
The results from this review are consistent with a non-randomized
study of the effect of socially marketed ITNs conducted in an area
with intense perennial malaria transmission in southern Tanzania
(Marchant 2002), and with the excluded randomized controlled
trial by D’Alessandro 1996 conducted in The Gambia, which has
low and highly seasonal transmission malaria. This supports the
current recommendations from the World Health Organization
to provide ITNs for pregnant women in all regions with stable
malaria transmission throughout sub-Saharan Africa regardless of
the degree of malaria transmission intensity.
Mass effect versus individual barrier protection: ITNs may be
implemented as a community control measure, where they are
distributed to the whole population, or as personal protection,
where pregnant women are specifically targeted to use nets. Four
of the five included trials were cluster randomized and used vil-
lages as the unit of randomization. The other trial assessed the
effect of ITNs when distributed as part of antenatal care and thus
randomized individual women. The effect of ITNs in the cluster
randomized trials reflects the combined effects of personal pro-
tection (individual barrier protection) and area-wide reductions
in malaria transmission (community or mass effect). It is possible
that the mass killing effect on mosquito populations will have re-
sulted in stronger treatment effects supporting ITNs in the three
cluster randomized trials than would be seen in trials randomizing
individuals, as women in villages randomized to receive ITNs may
have benefited from the area wide reduction of the malaria vec-
tor. The KEMRI/CDC ITNs trial conducted in western Kenya
suggested that the community effect can be substantial (Hawley
2003). Similar considerations apply to the Dolan 1993 trial from
the Thai-Burmese border. Although this trial randomized individ-
ual women rather than communities, all the women lived in the
same densely populated refugee camps and some mass-effect by
the treated nets cannot be excluded.
Extrapolation of results from cluster randomized trials to predict
the impact in programmes that distribute ITNs to individual preg-
nant women, such as part of antenatal care, or vice versa without
taking the effect of coverage into account should be donewith care.
The three community randomized trials and the two individually
randomized trials also differed in the duration of protection during
pregnancy. The community randomized trials distributed ITNs
to all members of a community regardless of whether they were
pregnant, while the individual randomized trials enrolled women
when theywere, on average, in their second trimester.Mostwomen
included in the community randomized trials became pregnant
after the intervention was distributed and were as such protected
throughout pregnancy, unlike those in individual randomized tri-
als who would be protected only from the second trimester on-
wards. The risk of peripheral malaria parasitaemia is greatest in the
first 20 weeks of gestation, with malaria infection rates at delivery
approximating the levels in the postnatal period (Brabin 1983).
The most recent included trial from western Kenya, Njagi 2002,
is informative in this respect. This is the only trial that compared
the effects of ITNs with no nets using simple randomization by
individual allocated through antenatal clinics in an area with low
ITN coverage (little or no mass effect). This trial was conducted in
an area of western Kenya that was contiguous with the location of
ter Kuile 2003. They shared similar levels of malaria transmission,
socioeconomic and educational status, and ethnicity of the popu-
lation. They were also conducted at the same time period. The ef-
fect estimates in the two trials were remarkably similar, suggesting
that ITNs may work equally well when provided to individuals as
part of antenatal care in the second trimester as when provided to
entire communities.
The World Health Organization recommends the use of IPT as
well as ITNs for the prevention of malaria in pregnancy in areas
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where malaria is endemic in Africa (WHO/AFRO 2004). Njagi
2002 is also the only trial that simultaneously assessed the effect
of ITNs and IPT with sulfadoxine-pyrimethamine using a facto-
rial design that allows the comparison of the effects of each sin-
gle intervention and the combined use of ITNs and IPT. The re-
sults suggest that the additional clinical benefits of combined ap-
proaches on birthweight and maternal anaemia are small, if any.
ITNs provided no additional benefit to women also receiving the
two-dose regimen of IPT with sulfadoxine-pyrimethamine. The
benefit of ITNs in this group is likely to be restricted to the ef-
fects on the infants after birth with continued use of the net by
mother and newborn. Additional studies are required to evaluate
the cost-effectiveness of programmes that use single interventions
compared with those that use multipronged approaches to malaria
control.
Four of the five trials were conducted in areas of African where
malaria is endemic. The only trial conducted in Asia compared
ITNs with untreated nets on the Thai-Burmese border. There
was a statistically significant reduction in anaemia and fetal loss,
but there was no evidence of a beneficial effect on birthweight or
gestational age. Further efficacy studies are required before ITNs
can be recommended for the prevention of malaria in pregnancy
in Asia and Latin America.
Several limitations should be taken in account when considering
the results of the meta-analyses:
• For birth outcomes (haemoglobin, malaria, and
birthweight), the results of the cluster-randomized Shulman
1998 were based on women who delivered in hospital (75 used
ITNs and 55 had no nets). As numbers were small the results
were not adjusted for clustering and it is plausible that the
women who delivered in hospital were different to those who
delivered at home, which means they are unlikely to be
representative of all those randomized.
• In Shulman 1998 all women were visited at home at least
four weeks (range four weeks to nine months) after their expected
date of delivery to ascertain birth outcome in terms of stillbirths,
neonatal deaths, and maternal deaths. This range means that
there maybe variability in the reliability of the data collected.
• For birth outcomes, the results from Browne 2001 are
based on 847/1961 (43%) participants in the study due to
passive surveillance of birth outcomes.
• Njagi 2002 and Dolan 1993 randomized individuals
whereas the other trials were cluster randomized and may have a
herd effect present.
• ter Kuile 2003 presented results for women with no to three
previous pregnancies, and those with four or more previous
pregnancies. The results for the first group were combined with
subgroups considering women in their first or second pregnancy,
while Browne 2001 did not present results grouped by gravidity
for the dichotomous outcome measures. This means that
stratification by gravidity could not always be presented as
desired.
• Detection and treatment of anaemia and parasitaemia
during follow up varied between trials and is likely to have
impacted on associated outcome measures. If the intensity of
detection and treatment of haemoglobin levels and parasitaemia
is greater within the clinical trial than in routine clinical practice,
this could potentially reduce the effect of ITNs on these
outcomes. Dolan 1993 performed weekly blood tests and ter
Kuile 2003 tested monthly, which would rarely be part of routine
antenatal clinic care. Shulman 1998 and Njagi 2002 tested and
treated women only if they were suspected of being anaemic or
of having malaria, while procedures in Browne 2001 are unclear.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The use of ITNs reduces peripheral and placental parasitaemia,
increases maternal haemoglobin concentrations, increases mean
birthweight, and decreases the risk of fetal loss in the women in
their first to fourth pregnancies. The effects were apparent in the
community (cluster) randomized trials in which women benefited
from protection throughout pregnancy and from area-wide killing
of malaria vectors (community effect), and in individual protec-
tion studies where ITNs were distributed to individuals as part of
antenatal care in the latter half of pregnancy. ITNs should be an
integral part of strategies to prevent malaria in pregnant women
living in areas of Africa where malaria is endemic.
Implications for research
No further trials of ITNs in pregnancy are required in sub-Saharan
Africa and research efforts should focus instead on improving their
coverage in pregnant women. Further research is required of the
benefits of combining IPT and ITNs in a multipronged approach
to prevent malaria in pregnant women. Further research is also
required before this recommendation can be extended to Asia and
Latin America.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Browne 2001
Methods Cluster randomized controlled trial: 96 clusters, 48 per group
Generation of allocation sequence and allocation concealment: determined by “open ballot of community leaders”
Blinding: open
Inclusion of randomized participants in analysis: 1806/1961 (92%) had blood taken in the third trimester for malaria
and haemoglobin outcomes; 847/1961 (43%) had pregnancy outcomes reported
Participants 1961 pregnant women (1033 intervention and 928 control) of any parity who had attended the study clinic at least
once
Interventions 1. ITNs
Insecticide: permethrin (500 g/m2)
Size: rectangular; 4 sizes ranging between 190 cm and 100 cm in width and by 180 cm in length and 150 cm in
height
2. No nets
Outcomes 1. Malaria infection
2. Antenatal parasitaemia (by parity and season)
3. Antenatal anaemia
4. Low birthweight
5. Mean and standard deviation of birthweight
6. Haemoglobin
7. Placental parasitaemia
8. Stillbirth
Notes Location: living compounds in Kassena-Nankana district, Ghana
Date: June 1994 to April 1995
Malaria transmission: hyperendemic and perennial with peaks in the rainy season
Trial assessed the impact of ITN use on malaria and anaemia in pregnancy as a supplementary study in a major cluster
randomized trial of bed nets supported by WHO/TDR
Active surveillance was used to track all deliveries of the recruited women, but this had to be abandoned in favour of
passive surveillance after 6 months because of resource constraints
Browne 2001 G1, dry
Methods Browne 2001 results for women in first pregnancy during the dry season
Participants -
Interventions -
Outcomes -
Notes -
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Browne 2001 G1, wet
Methods Browne 2001 results for women in first pregnancy during the wet season
Participants -
Interventions -
Outcomes -
Notes -
Browne 2001 G2, dry
Methods Browne 2001 results for women in second pregnancy during the dry season
Participants -
Interventions -
Outcomes -
Notes -
Browne 2001 G2, wet
Methods Browne 2001 results for women in second pregnancy during the wet season
Participants -
Interventions -
Outcomes -
Notes -
Browne 2001 G3+, dry
Methods Browne 2001 results for women in third or greater pregnancy during the dry season
Participants -
Interventions -
Outcomes -
Notes -
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Browne 2001 G3+, wet
Methods Browne 2001 results for in third or greater pregnancy during the wet season
Participants -
Interventions -
Outcomes -
Notes -
Dolan 1993
Methods Individual randomized controlled trial
Generation of allocation sequence and allocation concealment: states “randomized”, but the methods not described
Blinding: ITNs versus untreated nets comparison double blind (participants, antenatal clinic staff, and supervising
physician)
Inclusionof randomizedparticipants in analysis: of 223 enrolled into ITNand untreated groups 203 (91%) completed
Participants Pregnant women of all parity
341 women enrolled; 34 were excluded from the analysis because they either delivered within 2 weeks of enrolment
or were lost to follow up
Interventions 1. ITNs
Insecticide: permethrin (500 g/m2)
Size (cm): 70 wide by 180 long by 150 high
Material: nylon, mesh size 196, denier 70
2. Untreated nets
3. No study nets, but some women in this group had their own family-size untreated nets supplied by the Consortium
of Christian Relief Organizations and Interaid
Additional interventions: women with uncomplicated Plasmodium falciparum were treated with quinine sulphate (30
mg salt/kg/d in 3 divided doses for 7 d), and Plasmodium vivax infections with chloroquine (25 mg/kg base over 3
d); severe cases of P. falciparum were treated with intravenous quinine in a local hospital
Outcomes 1. Malaria infection during pregnancy
2. Antenatal parasitaemia
3. Illness warranting hospitalization
4. Antenatal anaemia
5. Premature delivery
6. Stillbirth
7. Infant mortality
8. Low birthweight
9. Birthweight
Notes Location: 3 camps (Shoklo, Bonoklo, and Maesalit) for displaced people of the Karen ethnic minority, Thailand
Date: recruitment between October 1990 and September 1992
Malaria transmission: mesoendemic with estimated attack rates of 1.0/year in the under 10 years age group and 0.8/
year in older children and adults
In the published results the ’no study nets group’ was split into those who had no nets and those who had received
nets from the charity: we felt the validity of the no study nets control group was compromised and decided to use
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Dolan 1993 (Continued)
data only on the treated versus untreated nets comparison
Njagi 2002
Methods Individual randomized controlled trial
Generation of allocation sequence: enrolled women randomized into the 4 arms in blocks of 12 using computer-
generated random numbers; randomization numbers were prepared before the trial started and kept at each recruit-
ment centre until the end of the trial
Allocation concealment: method not described
Blinding: open for ITNs versus no nets comparison; double blind for sulfadoxine-pyrimethamine versus sulfadoxine-
pyrimethamine placebo comparison
Inclusion of randomized participants in analysis: 963 women were recruited, out of which 752 (78%) were followed
up to completion
Participants Women in their first or second pregnancy
Interventions 1. ITNs plus sulfadoxine-pyrimethamine
2. ITNs
3. Sulfadoxine-pyrimethamine
4. Placebo
Net size (cm): 190 wide by 180 long by 150 high
Net material: polyester
Outcomes 1. Malaria infection
2. Maternal death
3. Antenatal parasitaemia
4. Spontaneous miscarriage
5. Maternal anaemia
6. Haemoglobin
7. Stillbirth
8. Birthweight
Notes Location: Bondo District Nyanza province, Kenya
Date: July 1997 to September 1999
Malaria transmission: perennial with 2 peaks coinciding with the rainy seasons with 90 to 400 infective bites per
person annually
Njagi 2002 +SP
Methods Njagi 2002 results for ITNs nets plus sulfadoxine-pyrimethamine versus no nets plus sulfadoxine-pyrimethamine
Participants -
Interventions -
Outcomes -
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Njagi 2002 +SP (Continued)
Notes -
Njagi 2002 -SP
Methods Njagi 2002 results for ITNs plus placebo versus placebo
Participants
Interventions -
Outcomes -
Notes -
Shulman 1998
Methods Cluster randomized controlled trial: 56 clusters (28:28) each of approximately 1000 individuals
Generation of allocation sequence and allocation concealment: determined by “open ballot ”; information received
via personal communication from Christian Lengeler
Blinding: open
Inclusion of randomized participants in analysis: of 503 recruited 462 (91.8%) had third trimester blood sample,
130 (25.8%) delivered in hospital, and 497 (98.8%) followed up at least 4 weeks after delivery
Participants 503 women pregnant for the first time with singleton pregnancies or history of previous pregnancy that did not go
beyond 12 weeks
Interventions 1. ITNs
Insecticide: permethrin (500 g/m2)
Size (cm): 190 wide by 180 long by 150 high
Material: green
2. No nets
Additional interventions: all women with haemoglobin < 10 g/dL were given haematins and those with a positive
slide for malaria were treated with sulfadoxine-pyrimethamine; all women with severe anaemia also given sulfadoxine-
pyrimethamine irrespective of the results of their malaria smear, based on the assumption that those with negative
smear would be likely to have placental parasitaemia
Sufficient nets provided for all members of randomized households
Outcomes 1. Malaria infection
2. Antenatal parasitaemia
3. Antenatal anaemia
4. Haemoglobin
5. Placental parasitaemia
6. Stillbirth
7. Birthweight
8. Perinatal mortality
9. Neonatal mortality
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Shulman 1998 (Continued)
Notes Location: resident in rural populations Kilifi District, Kenya
Date: September 1994 to November 1995
Malaria transmission: endemic and perennial with peaks in the 2 rainy seasons with individuals on average receiving
10 infective bites per person per year (ranging from 1 every 2 years to nearly 60 per person per year)
The trial recruited pregnant women who came from a rural population that had already been randomized to receiving
or not receiving nets treated with permethrin (500 g/m2) as part of a trial assessing the effect of ITNs on childhood
mortality and severe malaria in children; randomization and distribution of nets had been finished by August 1993,
and this study was conducted between September 1994 and November 1995
ter Kuile 2003
Methods Cluster randomized controlled trial 79 villages: 60 villages described as ’non cohort’ with delivery data only, and 19
villages described as ’cohort’ with outcomes collected prior to delivery and at delivery
Generation of allocation sequence and allocation concealment: “open lottery”
Blinding: open
Inclusion of randomized participants in analysis: birth outcomes for 2754/2991 (92%); minimum of 764/780 (98%)
included in analysis of outcomes assessing the impact of nets during pregnancy
Participants 2991 pregnant women of all parity
Interventions 1. ITNs
Insecticide: permethrin; pretreated at distribution and re-treated biannually to maintain a target dose of 500 mg/m2
Size: not provided
Note: multiple nets provided to large households according to bed space measurements and baseline demographic
data, providing an intervention ITN coverage ratio of 1.5 persons per ITN
2. No nets
Outcomes 1. Malaria infection
2. Antenatal parasitaemia
3. Spontaneous miscarriage
4. Maternal anaemia
5. Haemoglobin
6. Premature delivery
7. Stillbirth
8. Birthweight
Notes Location: Rarieda Division (Asebo), Siaya district, Kenya
Malarial transmission: intense perennial transmission with 60 to 300 infected bites per person annually with peaks
in the 3 rainy seasons
Conducted within the context of a large community-based randomized controlled trial designed to assess the impact
of ITNs on mortality in children < 5 years of age. The mortality in children trial consisted of two main sites, Asebo
and Gem, but the study on the impact of ITNs in pregnancy was conducted in Asebo area only (200 km2). The trial
involved randomizing villages to the intervention group, in which all households received ITNs during the fourth
quarter of 1996 or control group which received ITNs in April 1999 after the trial was completed
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ter Kuile 2003 G1-4
Methods ter Kuile 2003 results for women in their first to fourth pregnancy
Participants -
Interventions -
Outcomes -
Notes -
ter kuile 2003 G5+
Methods ter Kuile 2003 results for women in their fifth or greater pregnancy
Participants -
Interventions -
Outcomes -
Notes -
ITN: insecticide-treated net; WHO/TDR: World Health Organization/United Nations Development Programme (UNDP)/World
Bank/WHO Special Programme for Research and Training in Tropical Diseases.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
D’Alessandro 1996 1. Cluster randomized trial that did not adjust for clustering in the analysis
2. Substantial proportions of missing data: of the 651 women in their first pregnancy recruited, only 358 (55%)
had blood samples collected at 32 weeks gestation that were used in the analysis; 537 (82%) were available
for the pregnancy outcomes but only 380 (58%) were available for birthweight with 289 (44%) available with
placenta biopsy; 319 (49%) had information on survival
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D A T A A N D A N A L Y S E S
Comparison 1. Insecticide-treated nets versus no nets
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Severe anaemia 4 Various (Fixed, 95% CI) Subtotals only
1.1 Odds ratio (third
trimester)
2 Various (Fixed, 95% CI) 0.77 [0.56, 1.08]
1.2 Risk ratio (at delivery) 2 Various (Fixed, 95% CI) 0.98 [0.63, 1.52]
1.3 Hazard ratio 2 Various (Fixed, 95% CI) 0.89 [0.61, 1.31]
2 Any anaemia 5 Various (Random, 95% CI) Subtotals only
2.1 Odds ratio (third
trimester)
1 Various (Random, 95% CI) 0.88 [0.71, 1.10]
2.2 Odds ratio (at delivery) 2 Various (Random, 95% CI) 0.95 [0.50, 1.79]
2.3 Hazard ratio 2 Various (Random, 95% CI) 0.90 [0.71, 1.13]
3 Haemoglobin (g/L) 11 Mean difference (Random, 95% CI) Subtotals only
3.1 Third trimester: first or
second pregnancy
5 Mean difference (Random, 95% CI) -0.04 [-2.41, 2.33]
3.2 Third trimester: third or
greater pregnancy
3 Mean difference (Random, 95% CI) 0.30 [-3.38, 3.97]
3.3 At delivery: first or second
pregnancy
3 Mean difference (Random, 95% CI) 1.95 [-2.61, 6.51]
4 Low birthweight 4 Various (Fixed, 95% CI) 0.80 [0.64, 1.00]
4.1 Risk ratio: first or second
pregnancy
3 Various (Fixed, 95% CI) 0.77 [0.61, 0.98]
4.2 Risk ratio: fifth or greater
pregnancy
1 Various (Fixed, 95% CI) 1.12 [0.56, 2.24]
5 Birthweight (kg) 10 Mean difference (Fixed, 95% CI) 0.06 [0.02, 0.09]
5.1 First or second pregnancy 8 Mean difference (Fixed, 95% CI) 0.05 [0.02, 0.09]
5.2 Third or greater pregnancy 2 Mean difference (Fixed, 95% CI) 0.08 [-0.13, 0.28]
6 Clinical malaria illness during
pregnancy
2 Various (Fixed, 95% CI) Totals not selected
6.1 Odds ratio 1 Various (Fixed, 95% CI) Not estimable
6.2 Hazard ratio 1 Various (Fixed, 95% CI) Not estimable
7 Peripheral parasitaemia 6 Various (Fixed, 95% CI) Subtotals only
7.1 Odds ratio: third trimester 2 Various (Fixed, 95% CI) 0.88 [0.73, 1.06]
7.2 Risk ratio: at delivery 4 Various (Fixed, 95% CI) 0.76 [0.67, 0.86]
7.3 Hazard ratio 2 Various (Fixed, 95% CI) 0.67 [0.52, 0.86]
8 Parasite density 8 Geometric mean ratio (Fixed, 95% CI) 0.93 [0.77, 1.11]
8.1 First or second pregnancy 6 Geometric mean ratio (Fixed, 95% CI) 0.82 [0.66, 1.02]
8.2 Third or greater pregnancy 2 Geometric mean ratio (Fixed, 95% CI) 1.28 [0.90, 1.82]
9 Placental parasitaemia 5 Risk Ratio (Random, 95% CI) 0.79 [0.63, 0.98]
9.1 First or second pregnancy 4 Risk Ratio (Random, 95% CI) 0.82 [0.61, 1.11]
9.2 Fifth or greater pregnancy 1 Risk Ratio (Random, 95% CI) 0.72 [0.48, 1.08]
10 Fetal loss 5 Risk Ratio (Fixed, 95% CI) 0.68 [0.48, 0.98]
10.1 First or second pregnancy 4 Risk Ratio (Fixed, 95% CI) 0.67 [0.47, 0.97]
10.2 Fifth or greater
pregnancy
1 Risk Ratio (Fixed, 95% CI) 1.02 [0.17, 6.23]
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Analysis 1.1. Comparison 1 Insecticide-treated nets versus no nets, Outcome 1 Severe anaemia.
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 1 Severe anaemia
Study or subgroup log [Various] Various Weight Various
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Odds ratio (third trimester)
Browne 2001 -0.2231 (0.1904) 77.9 % 0.80 [ 0.55, 1.16 ]
Shulman 1998 -0.3711 (0.3574) 22.1 % 0.69 [ 0.34, 1.39 ]
Subtotal (95% CI) 100.0 % 0.77 [ 0.56, 1.08 ]
Heterogeneity: Chi2 = 0.13, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 1.52 (P = 0.13)
2 Risk ratio (at delivery)
ter Kuile 2003 G1-4 -0.2231 (0.2592) 75.1 % 0.80 [ 0.48, 1.33 ]
ter kuile 2003 G5+ 0.59 (0.45) 24.9 % 1.80 [ 0.75, 4.36 ]
Subtotal (95% CI) 100.0 % 0.98 [ 0.63, 1.52 ]
Heterogeneity: Chi2 = 2.45, df = 1 (P = 0.12); I2 =59%
Test for overall effect: Z = 0.09 (P = 0.93)
3 Hazard ratio
ter Kuile 2003 G1-4 -0.3567 (0.2592) 57.3 % 0.70 [ 0.42, 1.16 ]
ter kuile 2003 G5+ 0.2151 (0.3004) 42.7 % 1.24 [ 0.69, 2.23 ]
Subtotal (95% CI) 100.0 % 0.89 [ 0.61, 1.31 ]
Heterogeneity: Chi2 = 2.08, df = 1 (P = 0.15); I2 =52%
Test for overall effect: Z = 0.57 (P = 0.57)
Test for subgroup differences: Chi2 = 0.76, df = 2 (P = 0.68), I2 =0.0%
0.2 0.5 1 2 5
Favours ITNs Favours no nets
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Analysis 1.2. Comparison 1 Insecticide-treated nets versus no nets, Outcome 2 Any anaemia.
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 2 Any anaemia
Study or subgroup log [Various] Various Weight Various
(SE) IV,Random,95% CI IV,Random,95% CI
1 Odds ratio (third trimester)
Browne 2001 -0.1278 (0.113) 100.0 % 0.88 [ 0.71, 1.10 ]
Subtotal (95% CI) 100.0 % 0.88 [ 0.71, 1.10 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.13 (P = 0.26)
2 Odds ratio (at delivery)
Njagi 2002 +SP 0.2776 (0.2246) 47.1 % 1.32 [ 0.85, 2.05 ]
Njagi 2002 -SP -0.3711 (0.2081) 52.9 % 0.69 [ 0.46, 1.04 ]
Subtotal (95% CI) 100.0 % 0.95 [ 0.50, 1.79 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 4.49, df = 1 (P = 0.03); I2 =78%
Test for overall effect: Z = 0.16 (P = 0.87)
3 Hazard ratio
ter Kuile 2003 G1-4 -0.2357 (0.0995) 46.3 % 0.79 [ 0.65, 0.96 ]
ter kuile 2003 G5+ 0 (0.0807) 53.7 % 1.00 [ 0.85, 1.17 ]
Subtotal (95% CI) 100.0 % 0.90 [ 0.71, 1.13 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 3.38, df = 1 (P = 0.07); I2 =70%
Test for overall effect: Z = 0.94 (P = 0.35)
0.2 0.5 1 2 5
Favours ITNs Favours no nets
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Analysis 1.3. Comparison 1 Insecticide-treated nets versus no nets, Outcome 3 Haemoglobin (g/L).
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 3 Haemoglobin (g/L)
Study or subgroup Mean difference (SE)
Mean
difference Weight
Mean
difference
IV,Random,95% CI IV,Random,95% CI
1 Third trimester: first or second pregnancy
Browne 2001 G1, dry 1.8 (2.551) 20.9 % 1.80 [ -3.20, 6.80 ]
Browne 2001 G1, wet -1.4 (2.7117) 19.1 % -1.40 [ -6.71, 3.91 ]
Browne 2001 G2, dry -3.2 (3.0718) 15.7 % -3.20 [ -9.22, 2.82 ]
Browne 2001 G2, wet -1.7 (2.3519) 23.5 % -1.70 [ -6.31, 2.91 ]
Shulman 1998 3.5 (2.551) 20.9 % 3.50 [ -1.50, 8.50 ]
Subtotal (95% CI) 100.0 % -0.04 [ -2.41, 2.33 ]
Heterogeneity: Tau2 = 0.44; Chi2 = 4.25, df = 4 (P = 0.37); I2 =6%
Test for overall effect: Z = 0.03 (P = 0.98)
2 Third trimester: third or greater pregnancy
Browne 2001 G3+, dry 3.8 (2.551) 31.5 % 3.80 [ -1.20, 8.80 ]
Browne 2001 G3+, wet -0.3 (1.8038) 49.6 % -0.30 [ -3.84, 3.24 ]
ter kuile 2003 G5+ -3.8 (3.52) 18.9 % -3.80 [ -10.70, 3.10 ]
Subtotal (95% CI) 100.0 % 0.30 [ -3.38, 3.97 ]
Heterogeneity: Tau2 = 4.33; Chi2 = 3.35, df = 2 (P = 0.19); I2 =40%
Test for overall effect: Z = 0.16 (P = 0.87)
3 At delivery: first or second pregnancy
Njagi 2002 +SP -2 (2) 41.4 % -2.00 [ -5.92, 1.92 ]
Njagi 2002 -SP 3 (2.2398) 35.8 % 3.00 [ -1.39, 7.39 ]
ter Kuile 2003 G1-4 6 (3.036) 22.8 % 6.00 [ 0.05, 11.95 ]
Subtotal (95% CI) 100.0 % 1.95 [ -2.61, 6.51 ]
Heterogeneity: Tau2 = 10.45; Chi2 = 5.69, df = 2 (P = 0.06); I2 =65%
Test for overall effect: Z = 0.84 (P = 0.40)
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Analysis 1.4. Comparison 1 Insecticide-treated nets versus no nets, Outcome 4 Low birthweight.
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 4 Low birthweight
Study or subgroup log [Various] Various Weight Various
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Risk ratio: first or second pregnancy
Njagi 2002 +SP 0.0862 (0.2775) 17.0 % 1.09 [ 0.63, 1.88 ]
Njagi 2002 -SP -0.3857 (0.2609) 19.2 % 0.68 [ 0.41, 1.13 ]
ter Kuile 2003 G1-4 -0.3285 (0.1568) 53.3 % 0.72 [ 0.53, 0.98 ]
Subtotal (95% CI) 89.5 % 0.77 [ 0.61, 0.98 ]
Heterogeneity: Chi2 = 1.98, df = 2 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 2.17 (P = 0.030)
2 Risk ratio: fifth or greater pregnancy
ter kuile 2003 G5+ 0.1133 (0.3536) 10.5 % 1.12 [ 0.56, 2.24 ]
Subtotal (95% CI) 10.5 % 1.12 [ 0.56, 2.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.32 (P = 0.75)
Total (95% CI) 100.0 % 0.80 [ 0.64, 1.00 ]
Heterogeneity: Chi2 = 2.99, df = 3 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 1.95 (P = 0.052)
Test for subgroup differences: Chi2 = 1.01, df = 1 (P = 0.32), I2 =1%
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Analysis 1.5. Comparison 1 Insecticide-treated nets versus no nets, Outcome 5 Birthweight (kg).
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 5 Birthweight (kg)
Study or subgroup Mean difference (SE)
Mean
difference Weight
Mean
difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 First or second pregnancy
Browne 2001 G1, dry 0.1 (0.149) 1.3 % 0.10 [ -0.19, 0.39 ]
Browne 2001 G1, wet -0.16 (0.1225) 1.9 % -0.16 [ -0.40, 0.08 ]
Browne 2001 G2, dry 0.05 (0.1036) 2.7 % 0.05 [ -0.15, 0.25 ]
Browne 2001 G2, wet 0.14 (0.1121) 2.3 % 0.14 [ -0.08, 0.36 ]
Njagi 2002 +SP -0.03 (0.0459) 13.6 % -0.03 [ -0.12, 0.06 ]
Njagi 2002 -SP 0.07 (0.0459) 13.6 % 0.07 [ -0.02, 0.16 ]
Shulman 1998 0 (0.0849) 4.0 % 0.0 [ -0.17, 0.17 ]
ter Kuile 2003 G1-4 0.0776 (0.0222) 58.1 % 0.08 [ 0.03, 0.12 ]
Subtotal (95% CI) 97.4 % 0.05 [ 0.02, 0.09 ]
Heterogeneity: Chi2 = 8.74, df = 7 (P = 0.27); I2 =20%
Test for overall effect: Z = 3.19 (P = 0.0014)
2 Third or greater pregnancy
Browne 2001 G3+, dry -0.14 (0.1975) 0.7 % -0.14 [ -0.53, 0.25 ]
Browne 2001 G3+, wet 0.16 (0.1227) 1.9 % 0.16 [ -0.08, 0.40 ]
Subtotal (95% CI) 2.6 % 0.08 [ -0.13, 0.28 ]
Heterogeneity: Chi2 = 1.66, df = 1 (P = 0.20); I2 =40%
Test for overall effect: Z = 0.73 (P = 0.46)
Total (95% CI) 100.0 % 0.06 [ 0.02, 0.09 ]
Heterogeneity: Chi2 = 10.45, df = 9 (P = 0.32); I2 =14%
Test for overall effect: Z = 3.27 (P = 0.0011)
Test for subgroup differences: Chi2 = 0.04, df = 1 (P = 0.84), I2 =0.0%
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Analysis 1.6. Comparison 1 Insecticide-treated nets versus no nets, Outcome 6 Clinical malaria illness
during pregnancy.
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 6 Clinical malaria illness during pregnancy
Study or subgroup log [Various] Various Various
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Odds ratio
Shulman 1998 -0.1625 (0.3044) 0.85 [ 0.47, 1.54 ]
2 Hazard ratio
ter Kuile 2003 G1-4 -0.3285 (0.6845) 0.72 [ 0.19, 2.75 ]
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Analysis 1.7. Comparison 1 Insecticide-treated nets versus no nets, Outcome 7 Peripheral parasitaemia.
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 7 Peripheral parasitaemia
Study or subgroup log [Various] Various Weight Various
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 Odds ratio: third trimester
Browne 2001 -0.1165 (0.0999) 88.7 % 0.89 [ 0.73, 1.08 ]
Shulman 1998 -0.1863 (0.2803) 11.3 % 0.83 [ 0.48, 1.44 ]
Subtotal (95% CI) 100.0 % 0.88 [ 0.73, 1.06 ]
Heterogeneity: Chi2 = 0.06, df = 1 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.32 (P = 0.19)
2 Risk ratio: at delivery
Njagi 2002 +SP 0 (0.2627) 6.1 % 1.00 [ 0.60, 1.67 ]
Njagi 2002 -SP -0.3567 (0.182) 12.7 % 0.70 [ 0.49, 1.00 ]
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(. . . Continued)
Study or subgroup log [Various] Various Weight Various
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
ter Kuile 2003 G1-4 -0.2877 (0.0783) 68.7 % 0.75 [ 0.64, 0.87 ]
ter kuile 2003 G5+ -0.3011 (0.1841) 12.4 % 0.74 [ 0.52, 1.06 ]
Subtotal (95% CI) 100.0 % 0.76 [ 0.67, 0.86 ]
Heterogeneity: Chi2 = 1.34, df = 3 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 4.32 (P = 0.000015)
3 Hazard ratio
ter Kuile 2003 G1-4 -0.478 (0.1506) 73.7 % 0.62 [ 0.46, 0.83 ]
ter kuile 2003 G5+ -0.1863 (0.2521) 26.3 % 0.83 [ 0.51, 1.36 ]
Subtotal (95% CI) 100.0 % 0.67 [ 0.52, 0.86 ]
Heterogeneity: Chi2 = 0.99, df = 1 (P = 0.32); I2 =0.0%
Test for overall effect: Z = 3.10 (P = 0.0019)
Test for subgroup differences: Chi2 = 3.36, df = 2 (P = 0.19), I2 =41%
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Analysis 1.8. Comparison 1 Insecticide-treated nets versus no nets, Outcome 8 Parasite density.
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 8 Parasite density
Study or subgroup
log
[Geometric
mean ratio]
Geometric
mean ratio Weight
Geometric
mean ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 First or second pregnancy
Browne 2001 G1, dry 0.5971 (0.4337) 4.7 % 1.82 [ 0.78, 4.25 ]
Browne 2001 G1, wet 0.181 (0.3477) 7.3 % 1.20 [ 0.61, 2.37 ]
Browne 2001 G2, dry -0.561 (0.4418) 4.5 % 0.57 [ 0.24, 1.36 ]
Browne 2001 G2, wet -0.2029 (0.3953) 5.7 % 0.82 [ 0.38, 1.77 ]
Njagi 2002 +SP -0.4577 (0.1966) 22.9 % 0.63 [ 0.43, 0.93 ]
Njagi 2002 -SP -0.1591 (0.1785) 27.7 % 0.85 [ 0.60, 1.21 ]
Subtotal (95% CI) 72.8 % 0.82 [ 0.66, 1.02 ]
Heterogeneity: Chi2 = 7.02, df = 5 (P = 0.22); I2 =29%
Test for overall effect: Z = 1.80 (P = 0.072)
2 Third or greater pregnancy
Browne 2001 G3+, dry -0.0054 (0.3598) 6.8 % 0.99 [ 0.49, 2.01 ]
Browne 2001 G3+, wet 0.3304 (0.208) 20.4 % 1.39 [ 0.93, 2.09 ]
Subtotal (95% CI) 27.2 % 1.28 [ 0.90, 1.82 ]
Heterogeneity: Chi2 = 0.65, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.37 (P = 0.17)
Total (95% CI) 100.0 % 0.93 [ 0.77, 1.11 ]
Heterogeneity: Chi2 = 12.11, df = 7 (P = 0.10); I2 =42%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Chi2 = 4.44, df = 1 (P = 0.04), I2 =77%
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Analysis 1.9. Comparison 1 Insecticide-treated nets versus no nets, Outcome 9 Placental parasitaemia.
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 9 Placental parasitaemia
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Random,95% CI IV,Random,95% CI
1 First or second pregnancy
Njagi 2002 +SP 0.0953 (0.2602) 14.6 % 1.10 [ 0.66, 1.83 ]
Njagi 2002 -SP -0.4943 (0.1944) 21.9 % 0.61 [ 0.42, 0.89 ]
Shulman 1998 0.7885 (0.6392) 3.0 % 2.20 [ 0.63, 7.70 ]
ter Kuile 2003 G1-4 -0.2614 (0.1021) 40.5 % 0.77 [ 0.63, 0.94 ]
Subtotal (95% CI) 80.0 % 0.82 [ 0.61, 1.11 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 5.99, df = 3 (P = 0.11); I2 =50%
Test for overall effect: Z = 1.27 (P = 0.20)
2 Fifth or greater pregnancy
ter kuile 2003 G5+ -0.3285 (0.2085) 20.0 % 0.72 [ 0.48, 1.08 ]
Subtotal (95% CI) 20.0 % 0.72 [ 0.48, 1.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.58 (P = 0.12)
Total (95% CI) 100.0 % 0.79 [ 0.63, 0.98 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 6.12, df = 4 (P = 0.19); I2 =35%
Test for overall effect: Z = 2.12 (P = 0.034)
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Analysis 1.10. Comparison 1 Insecticide-treated nets versus no nets, Outcome 10 Fetal loss.
Review: Insecticide-treated nets for preventing malaria in pregnancy
Comparison: 1 Insecticide-treated nets versus no nets
Outcome: 10 Fetal loss
Study or subgroup log [Risk Ratio] Risk Ratio Weight Risk Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 First or second pregnancy
Njagi 2002 +SP -0.3857 (0.4525) 16.0 % 0.68 [ 0.28, 1.65 ]
Njagi 2002 -SP -0.4463 (0.3596) 25.4 % 0.64 [ 0.32, 1.29 ]
Shulman 1998 -0.4005 (0.6383) 8.1 % 0.67 [ 0.19, 2.34 ]
ter Kuile 2003 G1-4 -0.3711 (0.2653) 46.7 % 0.69 [ 0.41, 1.16 ]
Subtotal (95% CI) 96.1 % 0.67 [ 0.47, 0.97 ]
Heterogeneity: Chi2 = 0.03, df = 3 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 2.14 (P = 0.032)
2 Fifth or greater pregnancy
ter kuile 2003 G5+ 0.0198 (0.9234) 3.9 % 1.02 [ 0.17, 6.23 ]
Subtotal (95% CI) 3.9 % 1.02 [ 0.17, 6.23 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.98)
Total (95% CI) 100.0 % 0.68 [ 0.48, 0.98 ]
Heterogeneity: Chi2 = 0.22, df = 4 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 2.10 (P = 0.036)
Test for subgroup differences: Chi2 = 0.19, df = 1 (P = 0.66), I2 =0.0%
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A D D I T I O N A L T A B L E S
Table 1. Detailed search strategies
Search set CIDG SRa CENTRAL MEDLINEb EMBASEb LILACSb
1 malaria malaria malaria malaria malaria
2 pregnan* pregnan* pregnan* pregnan* pregnan*
3 woman woman woman woman woman
4 women women women women women
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Table 1. Detailed search strategies (Continued)
5 3 or 4 3 or 4 3 or 4 3 or 4 3 or 4
6 1 and 2 and 5 1 and 2 and 5 1 and 2 and 5 1 and 2 and 5 1 and 2 and 5
7 net* net* net* net* net*
8 ITN* ITN* ITN* ITN* 6 and 7
9 ITM* ITM* ITM* ITM* -
10 7 or 8 or 9 7 or 8 or 9 7 or 8 or 9 7 or 8 or 9 -
11 6 and 10 6 and 10 6 and 10 6 and 10 -
aCochrane Infectious Diseases Group Specialized Register.
bSearch terms used in combination with the search strategy for retrieving trials developed by The Cochrane Collaboration (Higgins
2005); upper case: MeSH or EMTREE heading; lower case: free text term.
Table 2. Risk of bias assessmenta
Trial Generation of allocation
sequence
Allocation concealment Blinding Inclusion of all random-
ized participants in the
analysis
Dolan 1993 Method not described Not described Double blind (participants,
antenatal clinic staff, and
supervising physician) for
ITNs versus untreated nets
comparison
Adequate
Shulman 1998 Adequate Adequate Open Adequate for number with
a third trimester blood sam-
ple
Inadequate for
number women who deliv-
ered in hospital
Adequate for number fol-
lowed up at least 4 weeks af-
ter delivery
Adequate for number with
a third trimester blood sam-
ple
Inadequate for
number women who deliv-
ered in hospital
Adequate for number fol-
lowed up at least 4 weeks af-
ter delivery
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Table 2. Risk of bias assessmenta (Continued)
Browne 2001 Adequate Adequate Open Adequate for number with
blood
taken in third trimester for
malaria and haemoglobin
Inadequate
for number with pregnancy
outcomes reported
Njagi 2002 Adequate Not described Open for ITNs versus no
nets comparison
Double blind for sulfadox-
ine-
pyrimethamine (SP) versus
SP placebo comparison
Open for ITNs versus no
nets comparison
Double blind for sulfadox-
ine-
pyrimethamine (SP) versus
SP placebo comparison
Inadequate for number
evaluated at delivery
ter Kuile 2003 Adequate Adequate Open Adequate number for birth
outcomes and analysis of
outcomes assessing the im-
pact of nets during preg-
nancy
aDetails of methods used in individual trials are in the ’Characteristics of included studies’.
WH A T ’ S N E W
Last assessed as up-to-date: 12 February 2009.
Date Event Description
11 May 2009 Amended Types of intervention
...
Control
Women in both arms must also receive malaria chemoprophylaxis or IPT changed to Women in both arms
may also receive malaria chemoprophylaxis or IPT.
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H I S T O R Y
Protocol first published: Issue 3, 2002
Review first published: Issue 2, 2006
Date Event Description
13 February 2009 New search has been performed Search updated. No new studies were found.
25 July 2008 Amended Converted to new review format and minor edits.
15 November 2006 Amended 2007, Issue 1: Confidence interval corrected for one analysis of placental
parasitaemia
20 August 2006 Amended 2006, Issue 4: “Abortion or stillbirth” changed to “fetal loss”
C O N T R I B U T I O N S O F A U T H O R S
Carrol Gamble assessed potentially relevant trials for inclusion into the review, assessed the risk of bias in included studies, independently
extracted data, entered data into Review Manager, carried out the data analysis, and co-wrote the review. John Paul Ekwaru developed
the protocol, scanned the results of literature search for potential relevant trials, assessed potentially relevant trials for inclusion into the
review, independently extracted data, and co-wrote the review. Feiko ter Kuile reviewed the protocol and co-wrote the manuscript.
D E C L A R A T I O N S O F I N T E R E S T
Feiko ter Kuile was an author of two of the included trials. Carrol Gamble and Paul Ekwaru: none known.
S O U R C E S O F S U P P O R T
Internal sources
• Makerere University, Uganda.
• University of Liverpool, UK.
• Liverpool School of Tropical Medicine, UK.
External sources
• Department for International Development (DfID), UK.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Feiko ter Kuile joined the review team, the order of the outcome measures were restructured, and quasi-randomized controlled trials
were excluded to reflect changes in Cochrane Infectious Diseases Group guidelines.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Bedding and Linens; ∗Insecticides; Anemia [blood]; Antimalarials; Malaria [∗prevention & control]; Mosquito Control [∗methods];
Nitriles; Permethrin; Pregnancy Complications, Hematologic [blood]; Pregnancy Complications, Parasitic [∗prevention & control];
Pyrethrins; Randomized Controlled Trials as Topic
MeSH check words
Animals; Female; Humans; Pregnancy
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